PNC Financial Services Group
SWTX

PNC Financial Services Group’s SpringWorks Therapeutics SWTX Stock Holding History

PNC Financial Services Group’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,065
Closed -$191K – 5230
2025
Q2 		$191K Sell
4,065
-2,324
-36% -$103K ﹤0.01% 2243
2025
Q1 		$282K Buy
6,389
+677
+12% +$31.2K ﹤0.01% 1942
2024
Q4 		$206K Sell
5,712
-662
-10% -$23.1K ﹤0.01% 2190
2024
Q3 		$204K Buy
6,374
+1,259
+25% +$47K ﹤0.01% 2157
2024
Q2 		$193K Buy
5,115
+4,990
+3,992% +$210K ﹤0.01% 2173
2024
Q1 		$6.15K Buy
125
+97
+346% +$4.49K ﹤0.01% 3899
2023
Q4 		$1.02K Buy
28
+18
+180% +$470 ﹤0.01% 4312
2023
Q3 		$231 Hold
10
– – ﹤0.01% 4524
2023
Q2 		$262 Hold
10
– – ﹤0.01% 4643
2023
Q1 		$257 Hold
10
– – ﹤0.01% 4578
2022
Q4 		$260 Sell
10
-198
-95% -$4.88K ﹤0.01% 4610
2022
Q3 		$5K Buy
+208
New +$5.96K ﹤0.01% 3979
2021
Q2 		– Sell
-21
Closed -$2K – 4284
2021
Q1 		$2K Buy
21
+4
+24% +$313 ﹤0.01% 3975
2020
Q4 		$1K Buy
+17
New +$1.09K ﹤0.01% 3920

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

PNC Financial Services Group's SWTX Position: Q3 2025 in Review

PNC Financial Services Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,065 shares — an estimated $191K sold.

PNC Financial Services Group first reported a position in SWTX in Q4 2020 and held it in 14 quarters. The position peaked at $282K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • PNC Financial Services Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 4,065 SpringWorks Therapeutics shares in Q3 2025, an estimated $191K.
  • PNC Financial Services Group first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 14 quarters.
  • PNC Financial Services Group's SpringWorks Therapeutics position peaked at $282K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.